Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

In The News BÜBL™ Fashion Osteoporosis Canada launched a transformative campaign intended to disrupt the osteoporosis landscape, while shining a light on a disease that affects 2 million Canadians. VIEW […]

On behalf of Osteoporosis Canada’s Scientific Advisory Consultants and Osteoporosis Canada, we would like to announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. […]

VITAMIN D IS VERY IMPORTANT TO OUR BONE HEALTH When taken in the appropriate amount, vitamin D decreases our risk of falling and breaking bones. It is very common to […]

The B.C. Ministry of Health is conducting a survey of patients, caregivers, and advocacy groups to achieve input regarding osteoporosis therapies in British Columbia and B.C. PharmaCare coverage. We know […]

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

Everyone has at one time experienced acute pain. The recent article on “Osteoporosis and Pain-Helping Your Body Help Itself” explains acute pain as a pain that starts suddenly and has […]

Bed Rest If you have a new spine fracture that is painful, bed rest is recommended during the acute pain stage because lying down puts less pressure on the spine […]